[ad_1]
The U.S. health regulator approved Basilea Pharmaceutica’s antibiotic for bacterial infections including multidrug-resistant strains, the FDA said on Wednesday. The Switzerland-based company was seeking approval of its antibiotic ceftobiprole for the treatment of three…
[ad_2]